.png)
News:
Construction Design & Engineering
Posted: August 18, 2017
ARC designed Bristol-Myers Squibb project earns honors
Boston, MA The International Society for Pharmaceutical Engineering (ISPE) awarded the Biologics Development Building of Bristol-Myers Squibb, designed by ARC/Architectural Resources Cambridge, with a global Facility of the Year Award in the Facilities Integration category. The award is for the integration of two facilities developed simultaneously on the Devens, Massachusetts campus, the 230,000 s/f Biologics Development Building designed by ARC, and the 131,000 s/f Clinical Manufacturing Building designed by Clark, Richardson and Biskup.
The Bristol-Myers Squibb facilities were cited as an outstanding example of how to plan, design, and integrate new capabilities within an existing plant. The Facility of the Year Awards (FOYA) were presented at a ceremony held during ISPE’s Quality Manufacturing Conference in Arlington, VA.
“We are proud to honor the eight winners who not only share ISPE’s commitment to innovation, they also promote pharmaceutical manufacturing technology by demonstrating creativity and excellence in facility design, construction, and operations,” said John Bournas, ISPE CEO and President.
The Biologics Development Building (BDB) opened in January of 2016 as part of Bristol-Myers Squibb’s multi-phase master plan for the 89-acre Devens, Massachusetts campus. The four-story BDB includes research labs and associated office spaces for approximately 200 employees on its first and second floors. A vacant third floor is designed for future expansion, and will house up to approximately 100 additional employees. The fourth-floor serves as a penthouse for utilities. The BDB received a Leadership in Energy and Environmental Design (LEED®) Silver certification for its sustainable design.
Established in 2004, The FOYA program recognizes state-of-the-art projects utilizing new, innovative technologies to improve the quality of products, reduce the cost of producing high-quality medicines, and demonstrate advances in project delivery. The FOYA program provides a platform for the pharmaceutical science and manufacturing industry to showcase its accomplishments while sharing the development of new applications of technology.
MORE FROM Construction Design & Engineering
Timberline Construction Corp. completes renovations for Neurology and Infusion Center of New England
Foxborough, MA Timberline Construction Corp. (Timberline) has completed a 20,000 s/f healthcare construction project for the Neurology and Infusion Center of New England at 18 Washington St. The full interior renovation transforms an existing two-story medical office building into a purpose-built outpatient care environment that doubles the center’s clinical footprint, expands services and positions the growing practice for its next chapter.
.jpg)
Quick Hits
Columns and Thought Leadership
ABC-Mass. chairman’s message: Rent control isn’t the answer to our housing crisis - by Luiza Mills
As you may know, Massachusetts voters will be weighing in on a number of ballot initiatives in November. Among them is a proposal to impose the nation’s strictest statewide rent control policy. I’d like to tell you why the ABC MA Board
It’s time to lead: Confronting mental health in construction - by David Watts
As we close Mental Health Awareness Month, we must be clear: May isn’t just about ribbons, hashtags, or lunchtime mindfulness apps. It’s about responsibility to confront hard truths that linger in silence, and to challenge ourselves, as leaders in our industry, to do more.
Greenwood Credit Union City Hall Plaza nears completion - by Frank Picozzi
After several years of planning, construction, and anticipation, the community is eagerly awaiting the opening of the Greenwood Credit Union City Hall Plaza and outdoor skating rink later this month.
Navigating tariffs and material uncertainty in today’s construction market - by Karl Ginand and Tiffany Gallo
As headlines around tariffs seem to dominate the news daily, many considering construction projects have anticipated major cost escalations and widespread supply issues. While tariffs haven’t driven pricing spikes to the extent once feared, the lasting impact has been a new layer of uncertainty, affecting more than just budgets.
